MATX Stock Analysis: Matson | NYSE
Marine Shipping | NYSE, USA | Market Cap: 6.171m USD | 12M Return: 81.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 58.4M
EPS Trend: 71.6%
Qual. Beats: 0
Rev. Trend: 54.6%
Qual. Beats: -1
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Matson, Inc. (NYSE: MATX) is a U.S.-based marine transportation and logistics company headquartered in Honolulu, Hawaii, operating in two segments: Ocean Transportation and Logistics. The Ocean Transportation segment provides scheduled freight services connecting the mainland U.S. to non-contiguous domestic markets including Hawaii, Alaska, and Guam, as well as other Pacific island economies, carrying diverse cargo such as dry and refrigerated containers, food products, building materials, automobiles, and consumer goods. The company also operates an expedited China-to-Long Beach service supporting trans-Pacific supply chains. The Logistics segment offers stevedoring, terminal operations across Hawaiian and Alaskan ports, inland trucking, rail intermodal, less-than-truckload (LCL) consolidation, freight forwarding, and warehousing services. Matsons core non-contiguous trades are governed by the Jones Act, which requires goods shipped between U.S. ports to be carried on U.S.-built, -flagged, and -crewed vessels, creating a protected market for the company. Founded in 1882 and renamed Matson in 2012, the firm primarily serves the U.S. military, freight forwarders, retailers, and consumer goods manufacturers.
- China-Long Beach expedited service volumes drive Ocean Transportation revenue
- Hawaii and Alaska domestic cargo volumes anchor stable base revenue
- Fuel cost volatility pressures operating margins across shipping routes
| Net Income: 429.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -1.37 > 1.0 |
| NWC/Revenue: -2.82% < 20% (prev -2.25%; Δ -0.56% < -1%) |
| CFO/TA 0.12 > 3% & CFO 550.0m > Net Income 429.1m |
| Net Debt (952.4m) to EBITDA (782.8m): 1.22 < 3 |
| Current Ratio: 0.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (30.6m) vs 12m ago -7.83% < -2% |
| Gross Margin: 22.42% > 18% (prev 25.76%; Δ -3.34% > 0.5%) |
| Asset Turnover: 72.89% > 50% (prev 76.91%; Δ -4.02% > 0%) |
| Interest Coverage Ratio: 77.04 > 6 (EBIT TTM 516.2m / Interest Expense TTM 6.70m) |
| A: -0.02 (Total Current Assets 436.4m - Total Current Liabilities 529.9m) / Total Assets 4.58b |
| B: 0.53 (Retained Earnings 2.43b / Total Assets 4.58b) |
| C: 0.11 (EBIT TTM 516.2m / Avg Total Assets 4.55b) |
| D: 1.47 (Book Value of Equity 2.73b / Total Liabilities 1.85b) |
| Altman-Z'' = 3.90 = AA |
| DSRI: 0.93 (Receivables 257.9m/290.8m, Revenue 3.32b/3.48b) |
| GMI: 1.15 (GM 25.76% / 22.42%) |
| AQI: 0.90 (AQ_t 0.28 / AQ_t-1 0.31) |
| SGI: 0.95 (Revenue 3.32b / 3.48b) |
| TATA: -0.03 (NI 429.1m - CFO 550.0m) / TA 4.58b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of July 04, 2026, the stock is trading at USD 203.53 with a total of 473,000 shares traded. Over the past week, the price has changed by +3.65%, over one month by +9.54%, over three months by +22.04% and over the past year by +81.80%.
Current recommended Stop Loss: 195.50 (which is 3.9% or 1.3 ATR below the current price).
Matson has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy MATX.
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 231 | 13.5% |
P/E Trailing = 15.1276
P/E Forward = 19.1939
P/S = 1.8587
P/B = 2.1309
P/EG = 2.014
Revenue TTM = 3.32b USD
EBIT TTM = 516.2m USD
EBITDA TTM = 782.8m USD
Long Term Debt = 302.2m USD (from longTermDebt, last quarter)
Short Term Debt = 165.0m USD (from shortTermDebt, last quarter)
Debt = 1.05b USD (from shortLongTermDebtTotal, last quarter) + Leases 355.3m
Net Debt = 952.4m USD (calculated: Debt 1.05b - CCE 100.1m)
Enterprise Value = 7.12b USD (6.17b + Debt 1.05b - CCE 100.1m)
Interest Coverage Ratio = 77.04 (Ebit TTM 516.2m / Interest Expense TTM 6.70m)
EV/FCF = 17.03x (Enterprise Value 7.12b / FCF TTM 418.4m)
FCF Yield = 5.87% (FCF TTM 418.4m / Enterprise Value 7.12b)
FCF Margin = 12.60% (FCF TTM 418.4m / Revenue TTM 3.32b)
Net Margin = 12.92% (Net Income TTM 429.1m / Revenue TTM 3.32b)
Gross Margin = 22.42% ((Revenue TTM 3.32b - Cost of Revenue TTM 2.58b) / Revenue TTM)
Gross Margin QoQ = 17.67% (prev 24.82%)
Tobins Q-Ratio = 1.55 (Enterprise Value 7.12b / Total Assets 4.58b)
Interest Expense / Debt = 0.64% (Interest Expense 6.70m / Debt 1.05b)
Taxrate = 15.78% (80.4m / 509.5m)
NOPAT = 434.7m (EBIT 516.2m * (1 - 15.78%))
Current Ratio = 0.82 (Total Current Assets 436.4m / Total Current Liabilities 529.9m)
Debt / Equity = 0.39 (Debt 1.05b / totalStockholderEquity, last quarter 2.73b)
Debt / EBITDA = 1.22 (Net Debt 952.4m / EBITDA 782.8m)
Debt / FCF = 2.28 (Net Debt 952.4m / FCF TTM 418.4m)
Total Stockholder Equity = 2.70b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.42% (Net Income 429.1m / Total Assets 4.58b)
RoE = 15.90% (Net Income TTM 429.1m / Total Stockholder Equity 2.70b)
RoCE = 17.20% (EBIT 516.2m / Capital Employed (Equity 2.70b + L.T.Debt 302.2m))
RoIC = 10.56% (NOPAT 434.7m / Invested Capital 4.12b)
WACC = 8.64% (E(6.17b)/V(7.22b) * Re(10.02%) + D(1.05b)/V(7.22b) * Rd(0.64%) * (1-Tc(0.16)))
Discount Rate = 10.02% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -100.00 | Cagr: -5.92%
[DCF] Terminal Value 72.56% ; FCFF base≈441.2m ; Y1≈398.3m ; Y5≈340.9m
[DCF] Fair Price = 139.8 (EV 5.18b - Net Debt 952.4m = Equity 4.23b / Shares 30.3m; r=8.64% [WACC]; 5y FCF grow -12.01% → 2.50% )
EPS Correlation: 71.64 | EPS CAGR: 19.83% | SUE: 0.38 | # QB: 0
Revenue Correlation: 54.56 | Revenue CAGR: 2.66% | SUE: -0.96 | # QB: -1
EPS current Quarter (2026-06-30): EPS=3.72 | Chg30d=+2.10% | Revisions=+0% | Analysts=3
EPS next Quarter (2026-09-30): EPS=5.07 | Chg30d=+6.58% | Revisions=+40% | Analysts=3
EPS current Year (2026-12-31): EPS=14.48 | Chg30d=+3.58% | Revisions=+40% | GrowthEPS=+4.9% | GrowthRev=+2.5%
EPS next Year (2027-12-31): EPS=15.32 | Chg30d=+1.10% | Revisions=+40% | GrowthEPS=+5.8% | GrowthRev=+4.4%
[Analyst] Revisions Ratio: +55% (up=7, down=1)